课题基金 / 基金详情

Fatty Acid Biosynthesis in Cryptosporidium parvum

Fatty Acid Biosynthesis in Cryptosporidium parvum
小隐孢子虫中的脂肪酸生物合成
批准号:
7769923
负责人:
GUAN ZHU
金额:
$29.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-04-15 至 2012-02-29
关键词:
Acetyl-CoA CarboxylaseAcidsAcquired Immunodeficiency SyndromeAcyl Carrier ProteinAcyl Coenzyme AAnimalsAntibioticsBacteriaBiochemicalBioinformaticsBoxingCarbonCategoriesCellsCenters for Disease Control and Prevention (U.S.)ChemicalsChimeric ProteinsChlorineCoccidiaCoenzyme ACommunitiesCryptosporidiosisCryptosporidiumCryptosporidium parvumDataDevelopmentDiarrheaDiazepam Binding InhibitorDrug Delivery SystemsEimeriaElectronsEnzymesEssential Fatty AcidsFatty AcidsFatty-acid synthaseFigs - dietaryFluorescence Resonance Energy TransferGenomicsGoalsHandHumanImmunocompetentImmunocompromised HostIn VitroIndividualInfectionIntestinesLifeLipidsMalonyl Coenzyme AMedium chain fatty acidMembraneMetabolicMetabolic PathwayMetabolismMolecularMono-SMorbidity - disease rateOocystsOpportunistic InfectionsOrganismOxidoreductaseParasite ControlParasitesPathway interactionsPatientsPharmaceutical PreparationsPlantsPlasmodiumPlastidsPolyunsaturated Fatty AcidsProcessRecombinant ProteinsResearchResearch PersonnelResistanceSouth AmericaStressStructureTertiary Protein StructureToxoplasmaTransferaseUnited StatesUnited States National Institutes of HealthVacuoleVery Long Chain Fatty AcidVividrin akut AzelastinWaterWater Supplybasebiodefensechemical reactionchemotherapydehydraseeffective therapyenoyl reductasefatty acid biosynthesisfatty acid elongasesfatty acid metabolismfatty acid synthase IIfatty acid transportfeedingfoodborne pathogengastrointestinal epitheliumhigh throughput screeninginhibitor/antagonistlong chain fatty acidmaltose-binding proteinmortalitynitazoxanidepathogenphosphopantetheinyl transferasepolyketide synthasepolypeptideprogramstool

项目摘要

项目成果

GUAN ZHU的其他基金

相似基金

相关文献

中文摘要
翻译
小隐孢子虫是一种单细胞病原体,可引起人类和动物严重的水样腹泻
英文摘要
Cryptosporidium parvum is a unicellular pathogen that can cause severe watery diarrhea in humans and animals. This pathogen can cause one of the opportunistic infections in AIDS patients for which no complete effective treatment is yet available. Cryptosporidium is also a significant water- and food-borne pathogen, and listed as one of the Category B priority pathogens in the NIH biodefense research program. The slow development of anti-cryptosporidiosis chemotherapy is primarily due to the poor understanding on the basic metabolic pathways in this parasite. Many well-defined or promising drug targets found in other apicomplexans are either absent or highly divergent in C. parvum. Therefore, detailed molecular and functional studies on the unique C. parvum metabolic pathways are needed for the understanding and control of this parasite. Fatty acids are one of the essential components in all cells. We have pioneered the research on the fatty acid synthesis in C. parvum. Our current data have revealed that C. parvum differs from other apicomplexans by lacking Type II FAS and its associated apicoplast, and relying on three distinct pathway for elongating fatty acids (ie. a Type I modular fatty acid synthase (CpFASI), a polyketide synthase (CpPKSI), and a long chain fatty acyl elongase (CpLCEl). In addition, we have identified putative major components that constitute the highly streamlined fatty acid metabolism in C.parvum. These advances now allow us to rationally dissect the function of C. parvum fatty acid metabolism in detail. Our long-term goal is to delineate the function(s) of major components constituting the fatty acid metabolism in C. parvum and to explore this pathway as a rational drug target. Our hypothesis is that major enzymes involved in the C. parvum fatty acid metabolism differ from their counterparts in humans and animals at both structural and functional levels, and may serve as rational drug targets. In this proposal, we will focus on studying different mechanisms governing fatty acid elongation and activation in C. parvum by achieving the following three specific aims: 1) To delineate the molecular machineries governing the fatty acid synthesis in the parasite by functional analyses of CpFASI, CpPKS! and a membrane-associated fatty acid elongase. 2) To elucidate the molecular mechanisms involved in the activation and transporting of fatty acids by functional analyses of acyl-CoA synthases and fatty acyl-CoA binding protein. 3) To validate that fatty acid metabolic enzymes may serve as rational drug target in Cryptosporidium by discovering inhibitors selectively against, parasite fatty acid metabolic enzymes.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pone.0012593
发表时间: 2010-09-07
期刊: PloS one
影响因子: 3.7
作者: [Yu Y, Zhang H, Zhu G]
通讯作者: Zhu G
DOI: 10.1016/j.exppara.2008.12.014
发表时间: 2010-01
期刊: EXPERIMENTAL PARASITOLOGY
影响因子: 2.1
作者: [Rider, Stanley Dean, Jr., Zhu, Guan]
通讯作者: Zhu, Guan
Cryptosporidium parvum: the first protist known to encode a putative polyketide synthase.
小隐孢子虫:已知的第一个编码假定的聚酮合酶的原生生物。
DOI: 10.1016/s0378-1119(02)00931-9
发表时间: 2002
期刊: Gene
影响因子: 3.5
作者: [Zhu,Guan, LaGier,MichaelJ, Stejskal,Frantisek, Millership,JasonJ, Cai,Xiaomin, Keithly,JanetS]
通讯作者: Keithly,JanetS
Two distinct oxysterol binding protein-related proteins in the parasitic protist Cryptosporidium parvum (Apicomplexa).
寄生原生生物隐孢子虫(Apicomplexa)中两种不同的氧甾醇结合蛋白相关蛋白。
DOI: 10.1016/j.bbrc.2006.05.165
发表时间: 2006
期刊: Biochemical and biophysical research communications
影响因子: 3.1
作者: [Zeng,Bin, Zhu,Guran]
通讯作者: Zhu,Guran
11
    Developing Therapeutics against Giardia and Other Anaerobic Protozoa by Targeting Parasite Fatty Acyl-CoA Synthetase (ACS)
    • 批准号:
      9099754
    • 项目类别:
    • 资助金额:
      $19.9万
    • 财政年份:
      2015
    • 负责人:
      GUAN ZHU
    • 依托单位:
    Bacterial-type hexokinase (HK) in the opportunistic parasite Cryptosporidium parv
    • 批准号:
      8898712
    • 项目类别:
    • 资助金额:
      $17.78万
    • 财政年份:
      2014
    • 负责人:
      GUAN ZHU
    • 依托单位:
    Bacterial-type hexokinase (HK) in the opportunistic parasite Cryptosporidium parv
    • 批准号:
      8730780
    • 项目类别:
    • 资助金额:
      $21.44万
    • 财政年份:
      2014
    • 负责人:
      GUAN ZHU
    • 依托单位:
    Evaluation of marketed drugs for rapid development as anti-cryptosporidal agents
    • 批准号:
      8528014
    • 项目类别:
    • 资助金额:
      $18.61万
    • 财政年份:
      2012
    • 负责人:
      GUAN ZHU
    • 依托单位:
    国内基金
    海外基金
    具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
    • 批准号:
      22007039
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2020
    • 负责人:
      王黎明
    • 依托单位:
    海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
    手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
    对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
    • 批准号:
      21172061
    • 项目类别:
      面上项目
    • 资助金额:
      30.0万元
    • 批准年份:
      2011
    • 负责人:
      许新华
    • 依托单位: